|
Sun, 03/02/2025 - 22:03 |
Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain |
Lexicon Pharmac... |
|
Wed, 05/18/2022 - 17:23 |
Gabapentin an Effective Alternative to Opioids for Cancer Patients Receiving Radiation, Roswell Park Team Shows |
Roswell Park Ca... |
|
Fri, 05/06/2022 - 11:49 |
Memorandum & Articles of Association |
Lupin |
|
Tue, 04/21/2020 - 09:49 |
Researchers Discover Treatment for Spasticity in Mice, Following Spina... |
UniversityofCop... |
|
Thu, 04/16/2020 - 01:28 |
Researchers Discover Treatment for Spasticity in Mice, Following Spinal Cord Injuries |
UniversityofCop... |
|
Fri, 12/20/2019 - 09:22 |
FDA safety alert warns of respiratory depression risk with restless legs syndrome drugs |
American Academ... |
|
Mon, 07/22/2019 - 10:20 |
FDA approves first generics of Lyrica |
FDA |
|
Mon, 07/08/2019 - 07:51 |
Research Brief: Physicians receiving industry money are more likely to prescribe brand-name drugs |
UniversityofMin... |
|
Mon, 06/17/2019 - 11:46 |
Hypertension drug may hold promise for Alzheimers disease |
American Heart ... |
|
Fri, 05/24/2019 - 09:20 |
Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA (pregabalin) in Primary Generalized Tonic-Clonic Seizures |
Pfizer |
|
Sun, 04/14/2019 - 20:25 |
Daiichi Sankyo Launches Tarlige Tablets for Pain Treatment in Japan |
Daiichi Sankyo |
|
Tue, 01/08/2019 - 09:39 |
Daiichi Sankyo Announces Marketing Approval in Japan of Tarlige Tablets for Pain Treatment |
Daiichi Sankyo |
|
Tue, 12/11/2018 - 10:24 |
FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications |
FDA |
|
Mon, 11/26/2018 - 20:32 |
Pfizer Receives Six Months Pediatric Exclusivity for LYRICA (pregabalin) |
Pfizer |
|
Wed, 09/05/2018 - 20:50 |
Doctors Should Pause Before Prescribing High Dosages of Gabapentin, Duquesne University Study Finds |
Duquesne University |
|
Thu, 05/17/2018 - 09:00 |
LYRICA (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint |
Pfizer |
|
Thu, 02/15/2018 - 01:23 |
Daiichi Sankyo Submits Marketing Application for Mirogabalin in Japan |
Daiichi Sankyo |
|
Tue, 01/30/2018 - 08:49 |
Prescription drug addiction review launched |
MDDUS |
|
Thu, 10/12/2017 - 07:36 |
U.S. FDA Approves LYRICA CR (pregabalin) Extended-Release Tablets CV |
Pfizer |
|
Thu, 08/31/2017 - 01:22 |
Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabalin in Diabetic Peripheral Neuropathic Pain |
Daiichi Sankyo |
|
Wed, 08/16/2017 - 15:31 |
Scientists Discover Powerful Potential Pain Reliever |
University of Texas |
|
Thu, 06/29/2017 - 21:28 |
Daiichi Sankyo Announces Top-line Results from Phase 3 Global Clinical Development Program Evaluating Mirogabalin in Pain Syndromes |
Daiichi Sankyo |
|
Thu, 12/01/2016 - 06:14 |
LYRICA (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint |
Pfizer |
|
Mon, 11/07/2016 - 07:22 |
Teva Announces Approval of Generic Tribenzor in the United States |
Teva Pharmaceutical |
